- Investing Ideas
- /
- U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
U.S. Pharmaceuticals & Biotech High Return On Equity, Low Debt
Results
4
0 new
Stocks with a return on equity of over 30% and a debt to equity ratio below 1.
4 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
|---|---|---|---|---|---|---|---|---|---|---|
MEDP | US$314.96 | -13.0% | 13.8% | US$9.8b | US$349.32 | PE26.7x | E10.9% | n/a | ||
AGIO | US$54.41 | -7.2% | 147.8% | US$3.1b | US$53.88 | PE4.6x | E-56.7% | n/a | ||
PTGX | US$38.65 | -9.4% | 129.6% | US$2.3b | US$54.38 | PE13.5x | E-31.4% | n/a | ||
MDXG | US$9.24 | 23.7% | 22.1% | US$1.4b | US$13.00 | PE17.1x | E-1.9% | n/a |
Page 1 of 1